Open Philanthropy recommended a grant of $1,000,000 to 1Day Sooner for general support.
1Day Sooner seeks novel ways to advance the fight against infectious diseases, building on the contributions of human research participants worldwide, especially participants in human challenge trials (HCTs). In an HCT, adult volunteers are exposed to a pathogen in controlled circumstances, often to test a vaccine or treatment. 1Day Sooner advocates for the broader adoption of HCTs to accelerate development of countermeasures against pathogens including the hepatitis C virus, influenza, group A Streptococcus, and coronaviruses, among others.
1Day Sooner also conducts research and advocacy to explore related scientific, regulatory, and policy measures, such as advance market commitments and far-UV indoor air sanitization, that can be used both to reduce the burden of infectious diseases today and prepare the world against future pandemic threats.
This follows our November 2021 support and falls within our work on global health and wellbeing.